Regulatory Authorities in China and Japan Approve Clinical Trials for Anthos Therapeutics’…
Fewer than 26% of Chinese Patients with Atrial Fibrillation are Prescribed an Anticoagulant, while in Japan Almost One-Third of Patients are Undertreated Approximately 63% of Cancer Patients in China Experienced a Venous Thromboembolism…